About Us
Nanophysics & Beyond
Curadigm
The Management
Our Commitments
Healthcare Professionals
Scientific Publications
Patients
Patient Engagement
Investors
Corporate Presentation
Financial Calendar
Regulated Information
SEC Filings
Annual General Meetings
Shareholder Corner
Press Releases
Congresses & Events
Nanotalks
NBTXR3 Development
R&D Day
Our Expert Videos
Nanoblog
From Curie to Nano
Contact & Newsletter
Medical Device Vigilance – Pharmacovigilance
Medical Information
Join Us
Nous vous informons que ce site est conforme à la législation française actuelle sur les dispositifs médicaux.
Continuer
Rester sur la page
Nanobiotix announces the filing of an amended registration statement, including an estimated initial public offering range
Nanobiotix announces the start of the roadshow for its proposed global offering and proposed Nasdaq listing
7 December 2020
Nanobiotix announces temporary trading halt of its ordinary shares on Euronext Paris
11 December 2020
Nanobiotix announces the filing of an amended registration statement, including an estimated initial public offering range
Published by
Julie Ficheux
on
10 December 2020
No translations available for this page
